A branched fluorescent peptide probe for imaging of activated platelets

Molecular Pharmaceutics

Volumn 2, Issue 1, 2005, Pages 92-95

  Tung, Ching Hsuan ^a   Quinti, Luisa ^a   Jaffer, Farouc A ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Activated platelets; Fluorescence; IIb IIIa; Receptor imaging; Thrombi detection

Indexed keywords

AMINOCAPROIC ACID; ASPARTIC ACID; CYSTINE; GLUTAMIC ACID; GLYCINE; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PEPTIDE; PROLINE; SERINE; TRYPTOPHAN;

AMINO ACID SEQUENCE; ARTICLE; FLUORESCENCE; IMAGING; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOCYTE ACTIVATION; THROMBOSIS; THROMBUS;

BLOOD PLATELETS; DIAGNOSTIC IMAGING; FIBRINOGEN; FLUORESCENCE; FLUORESCENT DYES; HUMANS; MODELS, BIOLOGICAL; PEPTIDES; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOSIS;

EID: 14644402405     PISSN: 15438384     EISSN: None     Source Type: Journal    
DOI: 10.1021/mp0499048     Document Type: Article

References (18)

1. Coull, B. M.; Williams, L. S.; Goldstein, L. B.; Meschia, J. F.; Heitzman, D.; Chaturvedi, S.; Johnston, K. C.; Starkman, S.; Morgenstern, L. B.; Wilterdink, J. L.; Levine, S. R.; Saver, J. L. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association. Stroke 2002, 33, 1934-1942.
2. Naghavi, M.; Libby, P.; Falk, E.; Casscells, S. W.; Litovsky, S.; Rumberger, J.; Badimon, J. J.; Stefanadis, C.; Moreno, P.; Pasterkamp, G.; Fayad, Z.; Stone, P. H.; Waxman, S.; Raggi, P.; Madjid, M.; Zarrabi, A.; Burke, A.; Yuan, C.; Fitzgerald, P. J.; Siscovick, D. S.; de Korte, C. L.; Aikawa, M.; Juhani Airaksinen, K. E.; Assmann, G.; Becker, C. R.; Chesebro, J. H.; Farb, A.; Galis, Z. S.; Jackson, C.; Jang, I. K.; Koenig, W.; Lodder, R. A.; March, K.; Demirovic, J.; Navab, M.; Priori, S. G.; Rekhter, M. D.; Bahr, R.; Grundy, S. M.; Mehran, R.; Colombo, A.; Boerwinkle, E.; Ballantyne, C.; Insull, W., Jr.; Schwartz, R. S.; Vogel, R.; Serruys, P. W.; Hansson, G. K.; Faxon, D. P.; Kaul, S.; Drexler, H.; Greenland, P.; Muller, J. E.; Virmani, R.; Ridker, P. M.; Zipes, D. P.; Shah, P. K.; Willerson, J. T. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108, 1664-1672.
3. Eeckhout, E.; Kern, M. J. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur. Heart J. 2001, 22, 729-739.
4. Ruggeri, Z. M. Platelets in atherothrombosis. Nat. Med. 2002, 8, 1227-1234.
5. Lefkovits, J.; Plow, E. F.; Topol, E. J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N. Engl. J. Med. 1995, 332, 1553-1559.
6. Behan, M. W.; Storey, R. F. Antiplatelet therapy in cardiovascular disease. Postgrad. Med. J. 2004, 80, 155-164.
7. Almeda, F. Q.; Schaer, G. L. Noncardiac applications of glycoprotein IIb/IIIa inhibitors. Catheter Cardiovasc. Intervention 2004, 62, 530-538.
8. Hayashi, Y.; Katada, J.; Sato, Y.; Igarashi, K.; Takiguchi, Y.; Harada, T.; Muramatsu, M.; Yasuda, E.; Uno, I. Discovery and structure-activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist. Bioorg. Med. Chem. 1998, 6, 355-364.
9. Tung, C. H.; Gerszten, R. E.; Jaffer, F. A.; Weissleder, R. A novel near infrared fluorescence sensor for detection of thrombin activation in blood. ChemBioChem 2002, 3, 207-211.
10. Tung, C. H.; Ho, N. H.; Zeng, Q.; Tang, Y.; Jaffer, F. A.; Reed, G. L.; Weissleder, R. Novel Factor XIII Probes for Blood Coagulation Imaging. ChemBioChem 2003, 4, 897-899.
11. Jaffer, F. A.; Tung, C. H.; Gerszten, R. E.; Weissleder, R. In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler., Thromb., Vasc. Biol. 2002, 22, 1929-1935.
12. Jaffer, F. A.; Tung, C. H.; Wykrzykowska, J, J.; Ho, N. H.; Houng, A. K.; Reed, G. L.; Weissleder, R. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 2004, 110, 170-176.
13. Kim, D. E.; Schellingerhout, D.; Jaffer, F. A.; Weissleder, R.; Tung, C. H. Near infrared fluorescent imaging of cerebral thrombi and edema in a mouse model of cerebral venous sinus thrombosis. J. Cereb. Blood Flow Metab. 2005, in press.
14. Mahmood, U.; Tung, C. H.; Bogdanov, A., Jr.; Weissleder, R. Near-infrared optical imaging of protease activity for tumor detection. Radiology 1999, 213, 866-870.
15. Knight, L. C. Radiolabeled peptide ligands for imaging thrombi and emboli. Nucl. Med. Biol. 2001, 28, 515-526.
16. Botnar, R. M.; Perez, A. S.; Witte, S.; Wiethoff, A. J.; Laredo, J.; Hamilton, J.; Quist, W.; Parsons, E. C., Jr.; Vaidya, A.; Kolodziej, A.; Barrett, J. A.; Graham, P. B.; Weisskoff, R. M.; Manning, W. J.; Johnstone, M. T. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004, 109, 2023-2029.
17. Perrier, A. Labeling the thrombus: the future of nuclear medicine for venous thromboembolism? Am. J. Respir. Crit. Care Med. 2004, 169, 977-978.
18. Morris, T. A.; Marsh, J. J.; Chiles, P. G.; Konopka, R. G.; Pedersen, C. A.; Schmidt, P. F.; Gerometta, M. Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer. Am. J. Respir. Crit. Care Med. 2004, 169, 987-993.